The AMA found that OptumRx, Express Scripts, CVS Caremark and Prime Therapeutics controlled 75% of the national PBM market in ...

Data, behavioral insights, and experimentation can be used to understand how stress, motivation, and trust shape company ...

AI could play a meaningful role in advancing social care. Not by replacing people, but by helping them and organizations ...

For one ICU physician and startup CMO, the more immediate danger isn’t an autonomous system taking over medicine and leaving ...

The FDA is recruiting to fill vacancies on its advisory committees, informally known as adcomms. While these committees have ...

AstraZeneca’s equity investment in Summit Therapeutics comes with plans for clinical trial collaborations. The deal brings ...

Mirum Pharmaceuticals’ Atebrioz is the third FDA-approved drug for fibrodysplasia ossificans progressiva (FOP), but it brings ...

Tiny Health's Series B round was led by B Capital, with participation from Spero Ventures, The Venture City, Overwater Ventures, Black Opal Ventures, Denver Ventures, Pave Health Ventures, Alumni ...

DreaMed Diabetes has received FDA 510(K) clearance for MODI, a mobile app that uses CGM (continuous glucose monitoring) data ...

Without a doubt, most hospital nurses will be using AI within a few years. The question is whether the AI tools nurses use will be another fragmented layer of technology or true assistants to help ...

While SUD affects people across all demographics, a growing body of research and clinical experience makes one point clear: ...

Merck now has global rights to a SciBrunch Therapeutics drug candidate designed to block mutated versions of the ...